Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2

NCT05081427 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2022-11-29

No results posted yet for this study

Summary

This study is a prospective, observational, single-center, short-term cross-sectional study to assess the repeatability and reproducibility of a set of specified MRI quantitative biomarkers.

Conditions

  • Nonalcoholic Fatty Liver

Sponsors & Collaborators

Principal Investigators

  • Sudhakar Venkatesh, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05081427 on ClinicalTrials.gov